Pharsight

AMGEN RESEARCH MUNICH PATENTS FACING OPPOSITIONS

Top patents of AMGEN RESEARCH MUNICH facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2780375B1 11 Sep, 2019 Binding molecules for bcma and cd3 NA 9
EP2780374B1 21 Aug, 2019 Binding molecules for bcma and cd3 Nov, 2032 7
EP3228315B1 25 Nov, 2020 Prevention of adverse effects caused by cd3 specific binding domains Oct, 2031 2
EP2637670B2 08 Mar, 2017 Prevention of adverse effects caused by cd3 specific binding domains NA 2
EP3149480B1 Risk-stratification of b-precursor acute lymphoblastic leukemia patients NA 1
EP3411402B1 22 Dec, 2021 Bcma and cd3 bispecific t cell engaging antibody constructs NA 1
EP3412687B1 18 Mar, 2020 Methods for treating dlbcl NA 1
EP3018145B1 04 Apr, 2018 Means and methods for treating dlbcl NA 1